Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus

Overview of attention for article published in Human Genetics, May 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

patent: 22 patents

Citations

dimensions_citation: 134 Dimensions

Readers on

mendeley: 43 Mendeley

So far, Altmetric has seen 22 patents that reference this research output.

Decreased transcription of the human FCGR2B gene mediated by the -343 G/C promoter polymorphism and association with systemic lupus erythematosus

About this Attention Score

Mentioned by

Citations

Readers on

Method for altering plasma retention and immunogenicity of antigen-binding molecule

Application KR-20240027154-A

Republic of Korea

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Grant US-11454633-B2

United States of America

Methods and compositions for inhibiting CD32B expressing cells

Grant US-11447552-B2

United States of America

Methods and compositions for inhibiting CD32B expressing cells

Grant US-11434295-B2

United States of America

Methods and compositions for inhibiting CD32B expressing cells in IGG4-related diseases

Grant US-11365256-B2

United States of America

Anti-myostatin antibodies and methods of use

Grant US-11359009-B2

United States of America

Method for altering plasma retention and immunogenicity of antigen-binding molecule

Application KR-20220075441-A

Republic of Korea

Methods of neutralizing IL-8 biological activity

Grant US-11180548-B2

United States of America

RETENTION OF ANTIGEN-BINDING MOLECULES IN BLOOD PLASMA AND METHOD FOR MODIFYING…

Application EP-3825325-A2

European Patent Office

Method for altering plasma retention and immunogenicity of antigen-binding molecule

Application KR-20200121900-A

Republic of Korea

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Grant US-10738111-B2

United States of America

Nucleic acids encoding IL-8 antibodies

Grant US-10519229-B2

United States of America

POLYPEPTIDES WITH MUTANT HUMAN IgG4

Application WO-2018185284-A1

World Intellectual Property Organisation (WIPO)

Anti-myostatin antibodies, polypeptides containing variant Fc regions, and methods of use

Grant US-10000560-B2

United States of America

IL-8 antibodies

Grant US-9969800-B2

United States of America

Methods and compositions for inhibiting CD32B expressing cells

Grant US-9914778-B2

United States of America

Methods and compositions for inhibiting CD32b expressing cells

Grant US-9902773-B2

United States of America

Methods and compositions for inhibiting CD32B expressing cells

Grant US-9394366-B2

United States of America

Methods and compositions for inhibiting CD32b expressing cells

Grant US-9260523-B2

United States of America

Methods and compositions for inhibiting CD32B expressing cells

Grant US-9079960-B2

United States of America

RETENTION OF ANTIGEN-BINDING MOLECULES IN BLOOD PLASMA AND METHOD FOR MODIFYING…

Application KR-20140015501-A

Republic of Korea

IMMUNOPROTECTION OF THERAPEUTIC MOIETIES USING ENHANCED FC REGIONS

Application WO-2011097527-A2

World Intellectual Property Organisation (WIPO)